The main mission of the Oncology Department is to achieve excellence through research that will have a strong impact on reducing the cancer burden within the Luxembourg population and beyond. Within prioritized areas, our aim is to develop excellence within basic, translational and clinical cancer research. This includes the implementation of a personalised medicine programme. The main activities of the department are focused on experimental cancer research with a strong translational research profile. Research activities focus on the cellular and molecular mechanisms of tumor progression using a wide range of state-of-the-art technologies, including genomic, transcriptomic and proteomic analyses, as well as in vitro and in vivo imaging modalities using state-of-the art animal models for cancer research.
Director of Department
Prof. Rolf Bjerkvig has been appointed Head of the Oncology Department in January 2011. He currently holds the position of Professor of Anatomy and Cell Biology at the University of Bergen. He is also director of the KG-Jebsen Brain Tumour Research Centre. His primary interests are the elucidation of the mechanisms of tumor cell migration within the CNS and mechanisms of tumor angiogenesis and therapeutic approaches for the prevention of angiogenesis in brain tumors. Prof. Bjerkvig has been honored with numerous international science awards for his research in oncology.